significance level
[용어속성] Term
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
COVID-19에 대한 Arbidol(Umifenovir)의 효과: 무작위 대조 시험
Randomized Controlled Trial
[키워드] (Lopinavir/ritonavir
adjusted
Admission
age
Analysis
antiviral drugs
ARB
Arbidol
ARMS
assigned
Chest CT
Clinical improvement
contribute
Corona virus
cough
COVID-19
COVID-19 disease
criteria
determine
diagnosis of COVID-19
duration of hospitalization
Dyspnea
Effect
effective
Efficacy
eligible patient
ESR
examined
Fever
Final
final analysis
followed by
group
groups
Health Organization
hospital
Hospitalization
Hydroxychloroquine
ICU admissions
IHD
Improvements
independent
Kaletra
Laboratory
less
Lopinavir
Lopinavir/ritonavir
male
multicenter design
Multiple linear regression
multiple linear regression analysis
Na level
Open-label
open-label randomized controlled trial
oxygen
oxygen saturation
Patient
patients with COVID-19
peripheral
peripheral oxygen saturation
Peripheral oxygen saturation rate
Primary outcome
Randomized controlled trial
Randomly
recruited
relief
Result
Ritonavir
Sample size
significance level
significantly
supportive care
Symptom
the disease
therapy
time
treatments for COVID-19
Trial registration
two group
two groups
variable
WBC
WHO
World Health Organization
[DOI] 10.1186/s12879-020-05698-w PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s12879-020-05698-w PMC 바로가기 [Article Type] Randomized Controlled Trial
Blood markers (lymphocyte percentages, neutrophils, CRP and ESR) can help in prioritizing rRT-PCR test for suspected COVID-19 patients in countries with limited health resources
혈액 표지자(림프구 백분율, 호중구, CRP 및 ESR)는 의료 자원이 제한된 국가에서 COVID-19 의심 환자에 대한 rRT-PCR 검사의 우선 순위를 정하는 데 도움이 될 수 있습니다.
Research
[키워드] all the patients
Analysis
analyzed
AUC
best
Blood
blood count
blood markers
both sexes
C-reactive protein
CBC
Chain Reaction
characteristic
China
complete blood count
confidence limit
confidence limits
coronavirus
coronavirus disease
Coronavirus disease 2019
country
COVID-19
COVID-19 patient
CRP
Cutoff
decrease
erythrocyte sedimentation
erythrocyte sedimentation rate
ESR
female
Fisher
gold
gold standard
group
Health
health resources
help
helping
hospital
individual
Laboratory
limit
Liver function test
liver function tests
lymphocyte
Lymphocytes
male
Mann-Whitney test
marker
median age
Molecular diagnosis
neutrophil
Neutrophils
outbreak
Patient
PCR test
percentages
physician
plasma
Plasma levels
polymerase chain
polymerase chain reaction
positive RT-PCR
qualitative variables
quantitative variable
quantitative variables
Real-Time Reverse Transcription Polymerase Chain Reaction
receiver
receiver operating characteristic
reduced
renal function
renal function tests
resource
Result
reverse transcription
reverse transcription polymerase chain reaction
ROC
rRT-PCR
rRT-PCR test
rRT-PCR tests
RT-PCR
sedimentation rate
severe symptoms
significance level
significant increase
Spread
SPSS
statistical analysis
the patient
variable
was done
was tested
WBCs
[DOI] 10.11604/pamj.2020.37.331.25180 PMC 바로가기 [Article Type] Research
[DOI] 10.11604/pamj.2020.37.331.25180 PMC 바로가기 [Article Type] Research
Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET)
COVID-19에서 헬멧 연속 양압기 대 고유량 비강 캐뉼러: 실용적인 무작위 임상 시험(COVID HELMET)
Randomized Controlled Trial
[키워드] 1:1
90% power
clinical trial
COVID
COVID-19
COVID-19 cohort
COVID-19 epidemic
CPAP
detect
End-Expiratory Pressure
Evidence
feasible
Helmet CPAP
HFNC
High-flow nasal cannula
hypothesise
hypoxaemia
implication
International
intubation
Invasive mechanical ventilation
investigator
investigator-initiated
low-flow oxygen therapy
Mann-Whitney U test
nasal
nasal cannula
oxygen
Oxygen therapy
Patient
patient recruitment
PEEP
positive airway pressure
Positive end-expiratory pressure
Pragmatic
Primary outcome
randomised
Randomised controlled trial protocol
Randomised trial
reduce
required
Sample size
significance level
survival
treated
Trial registration
ventilator free day
ventilator free days
Ventilator-free days
VFD
with COVID-19
[DOI] 10.1186/s13063-020-04863-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s13063-020-04863-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
Survey on general awareness, mental state and academic difficulties among students due to COVID-19 outbreak in the western regions of Uganda
Research Article
[키워드] Academic
age
aggregate
carried
COVID-19
COVID-19 crisis
COVID-19 outbreak
evaluate
Final
group
highlight
lockdown
Mental
Mental state
pandemic
participated
Psychology
question
Region
regions
Research
Schools
significance level
SPSS
statistical
student
survey
Uganda
university
[DOI] 10.1016/j.heliyon.2020.e05454 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1016/j.heliyon.2020.e05454 PMC 바로가기 [Article Type] Research Article
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
An Assessment of the Novel COVISTRESS Questionnaire: COVID-19 Impact on Physical Activity, Sedentary Action and Psychological Emotion
Article
[키워드] Action
activity
analogue
Analysis
Anxiety
applied
approval
assessment
caused
Community
conducted
consequence
coronavirus
correlation
country
COVID-19
COVID-19 outbreak
COVID-19 pandemic
Depression
Descriptive statistics
distress
emotion
emotional
evaluated
female
Health
Impact
intensity
Isolation
male
measure
Measures
moderate
no correlation
novel
outbreak
participant
performed
physical
physical activity
Psychological
psychological Impact
question
questionnaire
reduced
reported
response
resulting
scale
sedentary time
selected
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
significance level
significant difference
Sociodemographic
Spearman
Stress
stress level
stressors
triggered
Visual
Wilcoxon signed-rank test
[DOI] 10.3390/jcm9103352 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm9103352 PMC 바로가기 [Article Type] Article
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
Letter
[키워드] 1:1
Ability to communicate
acute respiratory syndrome
addition
administration
age
Analysis
antipyretics
Arm
Blinding
calculated
clinical
clinical trial
Combination
common cold-like symptom
control group
coronavirus
cough
COVID-19
COVID-19 patient
criteria
decrease
defined
Dementia
difficulty
dissemination
effective
Efficacy
element
exclusion criteria
fatigue
female
Fever
Follow-up
group
H1N1 influenza
hospitals
Hypothesis
IMPROVE
in both group
include
Inclusion
Infection
Inpatient
Japan
Japanese
Kampo
Kampo medicines
lactating
less
malaise
Medicine
Mild-to-moderate
number
objective
occurred
outcome
Outpatient
parallel-group
participant
Patient
patients
positive
Prevention for severe stage
previous study
protocol
Psychiatric
random
Randomized
Randomized controlled trial
receive
recruited
registry
required
Research
Sample size
SARS-CoV-2
Severe infection
Severity of disease
Shortness of breath
significance level
significantly
sputum
Stage
steroid
Study protocol
survival
survival curve
Symptom
Symptom relief
symptomatic
temperature
the Kaplan-Meier method
the log-rank test
the median
the primary endpoint
the SARS-CoV-2
to define
treated
Treatment
Two-arm
website
[DOI] 10.1186/s13063-020-04746-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04746-9 PMC 바로가기 [Article Type] Letter
The prevalence of sleep disturbances among physicians and nurses facing the COVID-19 patients: a systematic review and meta-analysis
Research
[키워드] Anxiety
caused
conducted
coronavirus
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
criteria
cross-sectional study
database
disease
Effect
Epidemics
evaluate
examined
Google Scholar
group
Health
healthcare
Healthcare workers
heterogeneity
hospital
increase
Increasing
Intervention
Meta-analysis
Nurse
Nurses
Pathogens
physician
Physicians
Prevalence
psychological disorder
reduce
reported
Result
resulting
risk
Sample size
Science Direct
searched
selected
significance level
Sleep disturbance
Sleep disturbances
Stress
systematic review
the Egger’s test
was measured
was used
Web
[DOI] 10.1186/s12992-020-00620-0 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12992-020-00620-0 PMC 바로가기 [Article Type] Research
Human development, social vulnerability and COVID-19 in Brazil: a study of the social determinants of health
Research Article
[키워드] 95% confidence interval
Analysis
Brazil
Case fatality rate
conditions
confirmed case
coronavirus
Coronavirus disease 2019
correlation
country
COVID-19
COVID-19 incidence
deaths
ecological
Ecological study
Fatality rate
Health
Human Development
identify
incidence
Local
measure
Mortality
pandemic
Population
reached
Registered
Regression model
Result
significance level
social determinant
Social vulnerability
Spread
the disease
Transmission
were used
[DOI] 10.1186/s40249-020-00743-x PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s40249-020-00743-x PMC 바로가기 [Article Type] Research Article